About APL SALES I LLC
Apellis Pharmaceuticals is a biotechnology company focused on developing life-changing medicines by inhibiting the complement cascade for patients with debilitating diseases. The company was acquired by Biogen.
Developing life-changing medicines for challenging diseasesLeading in complement scienceTargeting the complement cascade to address multiple disease pathwaysResearch and development in geographic atrophy, rare kidney diseases, and blood disorders
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Veterans Affairs | $26K | |
| EMPAVELI 1080 MG | Department of Veterans Affairs | $26K | |
| EMPAVELI 1080 MG | Department of Veterans Affairs | $26K | |
| EMPAVELI 1080 MG | Department of Veterans Affairs | $26K | |
| EMPAVELI 1080 MG | Department of Veterans Affairs | $26K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to APL SALES I LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.